Back

Associations of cumulative exposure and change patterns of the normalised creatinine-to-cystatin C ratio with incident cardiovascular disease in CKM stage 0–3 adults: a CHARLS analysis

29 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology: myocardial infarction and cardiopulmonary exercise Epidemiology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Beibei Du

China-Japan Union Hospital of Jilin University, Changchun (China)

5 More presentations in this session

Presentation thumbnail
Depression and anxiety in a primary prevention study: a preliminary analysis from the REACT study
Doctor L. Pehrson (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Cardiopulmonary exercise performance in physiologic versus conventional pacing
Doctor I. Araujo (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Declining cardiovascular mortality in England and Wales (2013-2024) masks persistent regional, sex, and age-based inequalities: a joinpoint analysis
Doctor H. Awan (London, GB)
Abstract Slides
Presentation thumbnail
Characteristics, risk factor profiles, and cardiovascular outcomes in patients with ASCVD without prior ischemic events in Western Europe: The OPTIMUS-RISK Study
Assistant Professor M. Leening (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Elevated complement C3 in patients with familial hypercholesterolemia
Assistant Professor D. Cheon (Hwaseong, KR)
Abstract Slides

Access the full session

Session thumbnail
Epidemiology: myocardial infarction and cardiopulmonary exercise

The Event

Event poster

ESC Congress 2026

29 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Adherence to Nordic and Mediterranean dietary patterns may be associated with a lower absolute risk of incident atherosclerotic cardiovascular disease
1 September 2024
thumbnail
Congress Presentation
Association of NOS3 polymorphism with risk factors of cardiovascular diseases in healthy adults
29 June 2021
thumbnail
Congress Presentation
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM
29 August 2025
thumbnail
Congress Presentation
PowerAI-CVD: Chinese-specific artificial intelligence-powered predictive model for cardiovascular disease
25 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources